ID: ALA277550

Max Phase: Preclinical

Molecular Formula: C16H17N3O5

Molecular Weight: 331.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COCC(=O)C1CCn2c1nc1c2C(=O)C(C)=C(NC(C)=O)C1=O

Standard InChI:  InChI=1S/C16H17N3O5/c1-7-11(17-8(2)20)15(23)12-13(14(7)22)19-5-4-9(16(19)18-12)10(21)6-24-3/h9H,4-6H2,1-3H3,(H,17,20)

Standard InChI Key:  LKIISDMVFZATAV-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.33Molecular Weight (Monoisotopic): 331.1168AlogP: 0.37#Rotatable Bonds: 4
Polar Surface Area: 107.36Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.67CX Basic pKa: 2.43CX LogP: -0.80CX LogD: -0.80
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.85Np Likeness Score: -0.14

References

1. Schulz WG, Islam I, Skibo EB..  (1995)  Pyrrolo[1,2-a]benzimidazole-based quinones and iminoquinones. The role of the 3-substituent on cytotoxicity.,  38  (1): [PMID:7837221] [10.1021/jm00001a016]

Source